Blue Goat Cyber and CS Lifesciences to host exclusive luncheon at MedTech World Dubai 2026

On Day One of MedTech World Middle East | Dubai 2026, a select group of MedTech leaders will gather for a focused, closed-door luncheon that goes beyond product pitches and market optimism to address a tougher question: why do some companies scale globally while most never do?

Sponsored by Blue Goat Cyber and CS Lifesciences, the luncheon titled “Scaling or Stalling: Who Actually Wins in Global MedTech?” will take place on 12 February 2026 at the InterContinental Dubai Festival City, during the three-day MedTech World Middle East conference running from 11 to 13 February 2026.

Rather than spotlighting technology alone, the conversation will examine the forces that truly determine whether innovation translates into adoption, trust, and long-term growth.

A Conversation Designed to Challenge Assumptions

The session will be moderated by Mazin Gadir, Director of Healthcare Life Sciences at Alvarez & Marsal, who will take on the role of both moderator and challenger. Framing healthcare transformation as a people, culture, and decision-making challenge, not just a technical one, Mazin will push panelists and participants to rethink common assumptions around scale.

Drawing on both GCC and global perspectives, he will guide a candid discussion on why decision-making in healthcare is often slower and more complex than innovation cycles, and how this reality shapes what ultimately succeeds in the market.

Regulation and Readiness: Why Many Companies Stall

Edwin Lindsay, Managing Director and Principal Consultant at CS Lifesciences, will focus on the often-misunderstood relationship between regulation and growth.

Rather than viewing compliance as a barrier, Edwin will explore why regulatory strategy, quality systems, and operational discipline are frequently the deciding factors between companies that scale and those that plateau. Many promising MedTech solutions, he will argue, fail not due to weak products, but because they were never designed to operate at the enterprise level.

His perspective will highlight what “enterprise-ready” actually looks like in practice, and why early alignment with regulatory expectations can support, rather than slow, expansion.

“Regulatory readiness isn’t paperwork, it’s the operating system that lets a MedTech business scale. And it only works when it’s anchored in clinical evidence. Without clinical proof you don’t have a product story, you have a hypothesis, and regulators, payers, and hospital systems don’t buy hypotheses. The companies that break through are the ones that stop collecting ‘options’ and start making decisions early: what indication we’re pursuing, what claims we can defend, what evidence we need, and what quality system we’ll run. That decisiveness turns compliance into momentum and keeps growth from stalling at the point where the market demands enterprise-grade execution.”

Patient Safety and Cyber Readiness as Growth Drivers

Anchoring the discussion around patient safety, Christian Espinosa, CEO of Blue Goat Cyber, will connect cybersecurity and data governance directly to clinical risk and trust.

Christian will outline how cyber readiness, responsible AI, and strong data practices are no longer optional add-ons, but baseline expectations for hospitals, governments, and strategic partners. As healthcare systems become more connected, these capabilities increasingly influence procurement decisions and partnership opportunities.

His contribution will focus on how treating cybersecurity as a patient safety issue can strengthen credibility, reduce risk, and support sustainable growth.

“Cyber readiness isn’t an IT add-on. It is patient safety and market access. Hospitals and governments don’t scale what they can’t trust, and trust is earned by proving you can secure, monitor, and update your device across its lifecycle. The companies that win build cybersecurity in early, show it in the evidence, and sustain it in the field, because that is what turns risk into confidence.”

Who Really Wins in Global MedTech?

Across the discussion, the luncheon will explore key questions shaping the next phase of MedTech growth:

• Who actually decides what scales in healthcare
• Why most innovation never translates into influence or adoption
• How patient safety, trust, regulation, and politics intersect
• What global leaders must understand to compete across regions

By bringing together perspectives from regulation, cybersecurity, and operational leadership, the session aims to offer a clearer view of what it takes to move from innovation to impact.

Set within MedTech World Middle East | Dubai 2026, this luncheon reflects the event’s broader focus on real-world decision-making, where technology, policy, and patient outcomes meet.

Join the conversation at MedTech World Middle East | Dubai 2026

Taking place from 11 to 13 February 2026 at the InterContinental Dubai Festival City, MedTech World Middle East | Dubai 2026 brings together global MedTech leaders, innovators, regulators, and investors to examine what truly drives adoption and scale in healthcare.

From focused, high-level discussions like “Scaling or Stalling: Who Actually Wins in Global MedTech?” to panels, keynotes, and curated networking, the event offers a space for meaningful exchange and practical insight.

Learn more and secure your place at MedTech World Middle East | Dubai 2026.